Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis -: Comparative effects of different antigens

被引:0
|
作者
Houssien, DA
Jónsson, T [1 ]
Davies, E
Scott, DL
机构
[1] Natl Univ Hosp, Dept Immunol, Landspitalinn, IS-101 Reykjavik, Iceland
[2] Univ London Kings Coll Hosp, Dept Immunol, London SE5 8RX, England
关键词
rheumatoid arthritis; rheumatoid factor; disease activity score; bone erosions;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The value of rheumatoid factor (RF) isotypes for assessing rheumatoid arthritis (RA) remains debatable. We investigated whether using different antigens to measure RF alters the relationships between RF isotypes and clinical variables. The association between IgA and IgM RF, disease activity, and cumulative anatomical joint damage in RA was studied in 140 patients. The RF isotypes were measured using both rabbit IgG and horse IgG as antigens. Cumulative anatomical damage was assessed radiologically using Larsen's score and disease activity was determined by C-reactive protein (CRP), the health assessment questionnaire (HAQ), and a combined disease activity score (DAS). Patients positive for IgA RF and IgM RF against rabbit IgG had significantly higher disease activity and more radiological damage than negative patients. With horse IgG as antigen these differences were smaller or absent. Patients positive for only IgM RF had milder disease than patients positive for IgA RF with or without IgM RF. The clinical relationships of RF isotypes are related to the antigen used. Measuring IgA RI: against rabbit IgG provides most information about disease activity, functional impairment and joint damage.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [31] Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study
    Gomez, Edmund Luke
    Gun, Suk Chyn
    Somanath, Sushela Devi
    Chinna, Karuthan
    Radhakrishnan, Ammu K.
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 716 - 721
  • [32] Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in South Tunisian Patients With Rheumatoid Arthritis: Association With Disease Activity and Severity
    Ben Hamad, Mariem
    Marzouk, Sameh
    Kaddour, Neila
    Masmoudi, Hatem
    Fakhfakh, Faiza
    Rebai, Ahmed
    Bahloul, Zouhir
    Maalej, Abdellatif
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (01) : 21 - 26
  • [33] Disease activity measures for rheumatoid arthritis
    Dougados, M.
    Aletaha, D.
    van Riel, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : S22 - S29
  • [34] Mortality trends in rheumatoid arthritis: The role of rheumatoid factor
    Gonzalez, Angel
    Icen, Murat
    Kremers, Hilal Maradit
    Crowson, Cynthia S.
    Davis, John M., III
    Therneau, Terry M.
    Roger, Veronique L.
    Gabriel, Sherine E.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1009 - 1014
  • [35] Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity
    Alqudah, Mohammad A. Y.
    Al-azzam, Sayer
    Alzoubi, Karem
    Alkhatatbeh, Mohammad
    Alawneh, Khaldoon
    Alazzeh, Ola
    Ababneh, Bayan
    INFLAMMOPHARMACOLOGY, 2017, 25 (04) : 431 - 438
  • [36] Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity
    Mohammad A. Y. Alqudah
    Sayer Al-azzam
    Karem Alzoubi
    Mohammad Alkhatatbeh
    Khaldoon Alawneh
    Ola Alazzeh
    Bayan Ababneh
    Inflammopharmacology, 2017, 25 : 431 - 438
  • [37] The assessment of disease activity in rheumatoid arthritis
    Smolen, J. S.
    Aletaha, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (03) : S18 - S27
  • [38] Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis:: association with disease duration, rheumatoid factor production and the presence of shared epitope
    Lakos, G.
    Soos, L.
    Fekete, A.
    Szabo, Z.
    Zeher, M.
    Horvath, I. F.
    Danko, K.
    Kapitany, A.
    Gyetvai, A.
    Szegedi, G.
    Szekanecz, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 253 - 260
  • [39] Influence of rheumatoid factor on serum drug levels of TNF inhibitors with different structures in rheumatoid arthritis
    Martinez-Feito, A.
    Plasencia-Rodriguez, C.
    Novella-Navarro, M.
    Gehin, J. E.
    Hernandez-Breijo, B.
    Brenis, C. M.
    Villalba-Yllan, A.
    Fernandez, E.
    Monjo-Henry, I.
    Pascual-Salcedo, D.
    Nozal, P.
    Balsa, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (05) : 999 - 1005
  • [40] Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease-
    Oyama, Jun-ichi
    Node, Koichi
    INTERNAL MEDICINE, 2019, 58 (10) : 1373 - 1374